Expression of telomerase activity and oxidative stress in human hepatocellular carcinoma with cirrhosis

Table 1 Relationship between telomerase activity and clinico-pathologic factors in HCC

	Telomerase activity
	High	Low or loss	P value
Tumor size (cm)	7.7 ± 3.5	7.1 ± 3.6	0.664
Tumor grade (high/low)	9/4	4/4	0.245
Tumor stage (early/ advanced)	6/7	3/5	0.327
ALT (normal /abnormal)	9/2	6/4	0.212
Bilirubin (normal /elevated)	9/2	9/1	0.414
Platelet (normal/ decreased)	9/2	7/3	0.324
HbsAg (positive/negetive)	6/5	7/3	0.272
AFP (> 400U/< 400U)	7/5	5/5	0.309
Albumin (g/L)	39.2 ± 5.6	39.3 ± 4.2	0.946
Globulin (g/L)	28.6 ± 5.3	26.8 ± 6.5	0.423
γ-GT(U)	115.2 ± 98.7	108.9 ± 69.5	0.814

Table 2 Expression of MDA, GST and T-AOC ( ^-x±s)

	HCC	Cirrhosis	P value
MDA (nM/mL)	84.76 ± 26.98	49.49 ± 23.03	< 0.001
GST (U/mg)	8.18 ± 5.59	18.70 ± 5.20	< 0.001
T-AOC (U/mg)	0.257 ± 0.241	0.689 ± 0.302	< 0.001